These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38700304)

  • 21. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article on COVID-19 and Guillain-Barré syndrome.
    Patnaik UJ
    Front Biosci (Schol Ed); 2021 Jun; 13(1):97-104. PubMed ID: 34256532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential association between COVID-19 disease and Guillain-Barré syndrome.
    Ergin Beton O; Ozturk Tan O; Bilen S
    Neurol Res; 2022 Sep; 44(9):855-860. PubMed ID: 35348038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Study on the Epidemiology of COVID-19-Related Guillain-Barré Syndrome in the United States.
    Sharma A; Sharma A; Soubani AO
    J Clin Neuromuscul Dis; 2024 Jun; 25(4):178-183. PubMed ID: 38771227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Covid-19 associated Guillain-Barre Syndrome: Contrasting tale of four patients from a tertiary care centre in India.
    Nanda S; Handa R; Prasad A; Anand R; Zutshi D; Dass SK; Bedi PK; Pahuja A; Shah PK; Sharma B
    Am J Emerg Med; 2021 Jan; 39():125-128. PubMed ID: 33039230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-COVID-19 Immune-Mediated Neurological Complications in Children: An Ambispective Study.
    Saini L; Krishna D; Tiwari S; Goyal JP; Kumar P; Khera D; Choudhary B; Didel S; Gadepalli R; Singh K
    Pediatr Neurol; 2022 Nov; 136():20-27. PubMed ID: 36049379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
    Chakraborty U; Hati A; Chandra A
    Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 and Guillain-Barré Syndrome: Lessons from Viral Infections.
    Meidaninikjeh S; Sabouni N; Taheri M; Borjkhani M; Bengar S; Majidi Zolbanin N; Khalili A; Jafari R
    Viral Immunol; 2022 Jul; 35(6):404-417. PubMed ID: 35766944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barre syndrome and pulmonary embolism in an adult female with COVID-19 infection in Ghana: A case report.
    Tetteh-Wayoe E; Duodu F; Pekyi-Boateng PK; Agyeman Badu NB; Akpalu A; Adjei P
    Medicine (Baltimore); 2023 May; 102(20):e33754. PubMed ID: 37335689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative frequencies and clinical features of Guillain-Barré Syndrome before and during the COVID-19 pandemic in North China.
    Li Y; Zhao R; Li L; Xue H; Meng H; Li G; Liang F; Zhang H; Ma J; Pang X; Wang J; Chang X; Guo J; Zhang W
    BMC Infect Dis; 2024 May; 24(1):541. PubMed ID: 38816802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Guillain-Barré syndrome following SARS-CoV-2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines.
    García-Grimshaw M; Galnares-Olalde JA; Bello-Chavolla OY; Michel-Chávez A; Cadena-Fernández A; Briseño-Godínez ME; Antonio-Villa NE; Núñez I; Gutiérrez-Romero A; Hernández-Vanegas L; Del Mar Saniger-Alba M; Carrillo-Mezo R; Ceballos-Liceaga SE; Carbajal-Sandoval G; Flores-Silva FD; Díaz-Ortega JL; Cortes-Alcalá R; Pérez-Padilla JR; López-Gatell H; Chiquete E; Reyes-Terán G; Arauz A; Valdés-Ferrer SI
    Eur J Neurol; 2022 Nov; 29(11):3368-3379. PubMed ID: 35841212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guillain-Barré Syndrome in the COVID-19 Pandemic.
    Tawakul AA; Al-Doboke AW; Altayyar SA; Alsulami SA; Alfahmi AM; Nooh RT
    Neurol Int; 2021 Dec; 14(1):34-48. PubMed ID: 35076589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barre syndrome during COVID-19 pandemic: experience from a referral healthcare center in Mexico.
    López-Hernández JC; Pérez-Valdez EY; León-Manríquez E; Bazán-Rodríguez L; Galnares-Olalde JA; Jorge-de Saráchaga A; Briseño-Godínez ME; May-Mas RN; Vargas-Cañas ES
    Rev Neurol; 2021 Nov; 73(9):315-320. PubMed ID: 34676529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C; Rhie S; Suh M; Kang DR; Choi YJ; Bae GR; Choi YC; Jun BY; Lee JS
    Vaccine; 2015 Apr; 33(15):1815-23. PubMed ID: 25728315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Scopelliti G; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Broglio L; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Padovani A; Uncini A
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):751-756. PubMed ID: 33158914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
    Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
    J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
    Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
    Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.